Long Yu
- Cancer Research top 0.5%
- Cancer, Hypoxia, and Metabolism 22
- Cell Biology top 0.5%
- Microtubule and mitosis dynamics 33
- Endoplasmic Reticulum Stress and Disease 18
- Molecular Biology top 1%
- Ubiquitin and proteasome pathways 43
- RNA modifications and cancer 30
- RNA Research and Splicing 25
- Oncology top 1%
- Cancer-related Molecular Pathways 45
- Peptidase Inhibition and Analysis 18
- Immunology and Allergy top 2%
Long Yu
358 papers receiving 9.5k citations
Hit Papers
Peers
Comparison fields: 5 of 155
- Cancer Research 1.8k
- Cell Biology 1.7k
- Molecular Biology 5.9k
- Oncology 1.8k
- Immunology and Allergy 261
Countries citing papers authored by Long Yu
This map shows the geographic impact of Long Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Long Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Long Yu more than expected).
Fields of papers citing papers by Long Yu
This network shows the impact of papers produced by Long Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Long Yu. The network helps show where Long Yu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Long Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 9 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 2 | |
| 5 | 2023 | 3 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 8 | |
| 8 | 2023 | 14 | |
| 9 | 2023 | 42 | |
| 10 | 2022 | 2 | |
| 11 | 2022 | 14 | |
| 12 | 2020 | 40 | |
| 13 | 2017 | 45 | |
| 14 | 2014 | 61 | |
| 15 | 2012 | 83 | |
| 16 | 2009 | 71 | |
| 17 | 2008 | 22 | |
| 18 | 2008 | 33 | |
| 19 | Presymptomatic genetic diagnosis for consulters from a large Chinese family with juvenile open angle glaucoma. | 2006 | 9 |
| 20 | 2006 | 9 |
About Long Yu
Long Yu is a scholar working on Oncology, Cancer Research, Cell Biology, Molecular Biology and Immunology and Allergy, having authored 369 papers that have together received 9.6k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (45 papers), Ubiquitin and proteasome pathways (43 papers), Microtubule and mitosis dynamics (33 papers), RNA modifications and cancer (30 papers), RNA Research and Splicing (25 papers), Cancer, Hypoxia, and Metabolism (22 papers), Peptidase Inhibition and Analysis (18 papers) and Endoplasmic Reticulum Stress and Disease (18 papers). The work is most often cited by research in Cancer Research (1.8k citations), Cell Biology (1.7k citations), Molecular Biology (5.9k citations), Oncology (1.8k citations) and Immunology and Allergy (261 citations). Long Yu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Peter N. Devreotes, Bo Wan, Yihong Yao, Zhan Xiao, Chenji Wang, Lihuan Cao, Xianmei Yang, Pingzhao Zhang, Hexige Saiyin and Jiaxue Wu. Their work appears in journals such as Molecular Biology Reports, Biochemical and Biophysical Research Communications, PLoS ONE, Breast Cancer Research and Treatment and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.